KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Omega Healthcare Investors (OHI) over the last 17 years, with Q4 2025 value amounting to -$940.5 million.

  • Omega Healthcare Investors' Cash from Financing Activities fell 48637.15% to -$940.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$838.3 million, marking a year-over-year decrease of 328498.42%. This contributed to the annual value of -$838.3 million for FY2025, which is 328498.42% down from last year.
  • Omega Healthcare Investors' Cash from Financing Activities amounted to -$940.5 million in Q4 2025, which was down 48637.15% from -$139.0 million recorded in Q3 2025.
  • In the past 5 years, Omega Healthcare Investors' Cash from Financing Activities ranged from a high of $589.0 million in Q2 2025 and a low of -$940.5 million during Q4 2025
  • For the 5-year period, Omega Healthcare Investors' Cash from Financing Activities averaged around -$120.8 million, with its median value being -$162.4 million (2021).
  • In the last 5 years, Omega Healthcare Investors' Cash from Financing Activities skyrocketed by 74090.97% in 2024 and then crashed by 48637.15% in 2025.
  • Omega Healthcare Investors' Cash from Financing Activities (Quarter) stood at -$166.1 million in 2021, then grew by 2.51% to -$162.0 million in 2022, then tumbled by 140.65% to -$389.8 million in 2023, then soared by 162.45% to $243.4 million in 2024, then tumbled by 486.37% to -$940.5 million in 2025.
  • Its Cash from Financing Activities stands at -$940.5 million for Q4 2025, versus -$139.0 million for Q3 2025 and $589.0 million for Q2 2025.